Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Fan

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
The British Journal of Ophthalmology|May 18, 2021
Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension studyKun Liu, Hanying Wang, Wei He, et al.
Physical Chemistry Chemical Physics : PCCP|January 7, 2016
A comprehensive comparison of dye-sensitized NiO photocathodes for solar energy conversionChristopher J Wood, Gareth H Summers, Charlotte A Clark, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 24, 2025
Efficient and Stable Tandem Solar Cells With Conformal Solution-Processed Perovskite on Fully Textured SiliconCao Yu, Wei Shi, Zhiliang Liu, et al.
Ophthalmology and Therapy|November 21, 2023
Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 TrialBing Li, Ke Fan, Tonghe Zhang, et al.
Seminars in Ophthalmology|March 13, 2025
Treat-And-Extend Versus Pro Re Nata Regimen of Intravitreal Conbercept Injection for Neovascular Age-Related Macular Degeneration: Results from COCOA, a Prospective, Open-Label, Multicenter, Randomized Phase IV Clinical TrialYaoyao Sun, Wenfang Zhang, Bojie Hu, et al.
Ophthalmology. Retina|August 30, 2024
Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II TrialJunran Sun, Yanping Song, Yuanyuan Gong, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
The British Journal of Ophthalmology|May 18, 2021
Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension studyKun Liu, Hanying Wang, Wei He, et al.
Physical Chemistry Chemical Physics : PCCP|January 7, 2016
A comprehensive comparison of dye-sensitized NiO photocathodes for solar energy conversionChristopher J Wood, Gareth H Summers, Charlotte A Clark, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 24, 2025
Efficient and Stable Tandem Solar Cells With Conformal Solution-Processed Perovskite on Fully Textured SiliconCao Yu, Wei Shi, Zhiliang Liu, et al.
Ophthalmology and Therapy|November 21, 2023
Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 TrialBing Li, Ke Fan, Tonghe Zhang, et al.
Seminars in Ophthalmology|March 13, 2025
Treat-And-Extend Versus Pro Re Nata Regimen of Intravitreal Conbercept Injection for Neovascular Age-Related Macular Degeneration: Results from COCOA, a Prospective, Open-Label, Multicenter, Randomized Phase IV Clinical TrialYaoyao Sun, Wenfang Zhang, Bojie Hu, et al.
Ophthalmology. Retina|August 30, 2024
Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II TrialJunran Sun, Yanping Song, Yuanyuan Gong, et al.
Pageof 21